JAMA Network Home
Sign In
Viewpoint

Assessing the Case Against Direct-to-Consumer Drug Advertisements

JAMA Health Forum 10.1001/jamahealthforum.2025.5325

November 14, 2025 at 11:00 AM EST

Read the full article

This Viewpoint assesses concerns regarding direct-to-consumer advertising of prescription drugs.

Corresponding Author: Abby Alpert, PhD, University of Pennsylvania, 3641 Locust Walk, Philadelphia, PA 19104 (alpertab@wharton.upenn.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2025.5325?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111425

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks